Immunoglobulin National Society (IgNS)的动态

#AllogeneicCellTherapiesSummit is less than a week away! ?? Visit the Gift of Life Biologics team at booths #1 and #2 to learn about our services and how we can help elevate your research, clinical, or commercial development. ???????? We look forward to seeing you there! #CellTherapy #GeneTherapy #Biologics Hanson Wade Group

Unlocking the differences between biologics and biosimilars! ?? Biologics undergo thorough clinical testing to ensure safety and efficacy, offering targeted treatment for various diseases. In contrast, biosimilars demonstrate similarity to their reference product and are developed after the patent of the original biologic expires. Understanding these regulatory pathways is crucial for informed healthcare decisions.?? #biologics #biosimilars #regulatorypathways #healthcareinnovation

Vasculitis is a serious condition that requires prompt medical attention. The global vasculitis treatment market is growing rapidly, driven by advancements in biologics, immunosuppressive therapies, and increased awareness about early diagnosis. Patients with vasculitis can now access more effective treatments than ever before. To learn more about the latest trends in vasculitis treatment, explore our new report! Learn more. https://lnkd.in/ebwnb7H2 For Downloade Sample Report. https://lnkd.in/e6QnKdyi #Vasculitis #Healthcare #Biologics #MedicalResearch

?? #Whitepaper: "Inside the Growing Precision Therapy Market and the Crucial Role of pDNA Manufacturing". ? The role of pDNA as a carrier of therapeutic genes enables researchers and clinicians to develop personalized treatment approaches. ? Partnering with CDMOs helps biotechs navigate pDNA manufacturing challenges, including regulatory standards and small patient populations, speeding up the journey to market. ? Learn more about the cGMP pDNA manufacturing process and trends in our whitepaper ?? https://lnkd.in/gUXW9e3K #pDNA #Biologics #CRDMO #Syngene

?? How could you deliver your drug product to the brain? ?? Have you considered the nose as a potential route of administration? "An integral part of developing dry powder biologics for nasal delivery is in the device selection and testing of the delivered dose to ensure maximum delivery of the biologic into the correct areas of the nasal geometry." Discover more about the opportunities and challenges of developing dry powder biologics for nasal delivery in our latest whitepaper by Richard Johnson. Download to learn more ?? https://lnkd.in/gUuU2mtb #CDMO #Whitepaper #Biologics

(Benefit-Risk Management / Cell-based Biologics / New DRAFT Guidance on Cellular Testing) Let's start with some new vocabulary alerts for the non-cellular therapy folks like "Master Cell Bank" and "Allogenic". If you're in continuous learning mode, may want to brief thru this guidance and get your medical/scientific dictionary ready to reference. Enjoy. #fda #biologics #cber #cellbank #cellcultures #safetytesting #cgt #cellulartherapy Primer page: https://lnkd.in/e7fdMdvr

Hello from Festival of Biologics! Check out the latest #insilico #immunogenicity research from EpiVax, Inc. - poster 28 #fearlessscience #festivalofbiologics #antibodies #biologics

Thanks to the attendees, exhibitors, & organizers for contributing to another successful CPHI North America. Time to bid farewell to #Philadelphia & get ready for #TIDES USA in Boston. Let's chat about your needs in #API #CMC! #pharmaceuticalmanufacturing #CDMO #Olon #GMP #drugdevelopment #processdevelopment #processvalidation #processengineering #HPAPI #ADC #peptides #biologics #bioprocess #pharma #organicchemistry #biosimilars

Ziccum’s CEO Ann Gidner delivered a presentation at BioStock 2024 Global Forum on May 30th, 2024 in Lund, Sweden, outlining Ziccum’s proprietary technology LaminarPaceTM, a formulation and drying technology for delicate liquid biologics that turns delicate vaccines and biologics, including mRNA, into robust thermostable dry powders. Read the full article here: https://lnkd.in/dKMfVXtM Watch the presentation here: Ziccum | BioStock Global Forum 2024 (youtube.com) #ziccum #laminarpace #disruptivetechnology #disruptive #innovation #biologics #mrna #rna #mrnalnp #lipidnanoparticles #biologics #dryingbiologics #vaccine #formulation #drugformulation #lnpformulation #thermostability #vaccinedelivery #inhalation #inhaledbiologics #particleengineering #carbonfootprint #vaccinedevelopment #drugdevelopment

Biologics have expanded treatment options for a multitude of diseases. Traditionally, biologics workflows have relied on a patchwork of solutions from multiple providers, leading to a fragmented approach. Now, more labs are choosing a single vendor and seeing measurable gains. Our latest blog explores this growing trend and highlights benefits such as streamlined training and technical support to unified workflows. Read here: https://ow.ly/Xuev50RiMtR #Biologics #Therapeutics #CellLineDevelopment #MoleculeDevelopment